At the conclusion of this presentation, participants should be able to:
Assess factors that influence patients’ perceptions of risk
Define absolute risk, attributable risk, relative risk, and odds ratio
Explain the differences, advantages, and disadvantages of descriptive studies, observational studies, and prospective studies
Demonstrate effective risk communication strategies
Accreditation Information
Physicians:
Accreditation The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation ARHP designates this internet enduring material for a maximum of 1AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others:
A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.
Sponsoring Information
This program is sponsored by the Association of Reproductive Health Professionals.
Funding Information
This project is funded through educational grants from Bayer HealthCare Pharmaceuticals, Merck and Co., and Teva Pharmaceuticals.
Disclosure Information
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Target Audience
The intended audiences for this activity are health professionals who provide reproductive health services, including physicians, nurse practitioners, nurse-midwives, physician assistants, educators, researchers, and other professionals who work in obstetrics/gynecology, family medicine, and related fields.
Advisory Committee Disclosures
Jeffrey T. Jensen, MD, MPH (Course Director/Instructor)
Consulting fees from Bayer HealthCare Pharmaceuticals, Agile, Merck, HRA Pharma, Population Council; Fees received for promotional services from Bayer HealthCare Pharmaceuticals; Research funds from NICHD, Population Council, Bayer HealthCare Pharmaceuticals, Med360
Anne Moore, DNP, APRN, FAANP (Instructor/Peer Reviewer)
Merck Implanon/Nexplanon trainer
David Turok, MD, MPH (Planner/Instructor)
Consulting fees from Bayer HealthCare Pharmaceuticals; Research funds from Med360
James Trussell, PhD (Planner/Instructor)
Consulting fees from Bayer HealthCare Pharmaceuticals Economics Health Group Berlin
ARHP Staff/Consultant Disclosures
Ellen Cohen, Cert Ed, Dip Ed
Director of Education
Nothing to disclose
Aleya Horn Kennedy, MPP
Program Manager
Nothing to disclose
Carole Chrvala, PhD
Consultant (Medical Writer)
Nothing to disclose
Beth Jordan, MD
Medical Director
Nothing to disclose
By clicking this check box, you acknowledge that you have read above information
Association of Reproductive Health Professionals – East
1901 L Street, NW, Suite 300, Washington, DC 20036
(202) 466-3825 | ARHP@arhp.org
Association of Reproductive Health Professionals – West
1330 Broadway, Suite 1100, Oakland, CA 96412
(202) 466-3825 | ARHP@arhp.org
Looking for medically accurate, up-to-date, evidence-based educational programming for health care providers and materials for patients on all reproductive health topics, including abortion, contraception, HPV, menopause, menstruation, pregnancy, sexuality? Look no further than the Association of Reproductive Health Professionals (ARHP) – the leading source for trusted medical education and information on reproductive and sexual health.
